Literature DB >> 21808295

Pharmacotherapy: does selenium supplementation improve Graves ophthalmopathy?

Terry J Smith, Raymond S Douglas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21808295     DOI： 10.1038/nrendo.2011.128

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  10 in total

Review 1.  Pharmacological aspects of pentoxifylline with emphasis on its inhibitory actions on hepatic fibrogenesis.

Authors:  C Windmeier; A M Gressner
Journal:  Gen Pharmacol       Date:  1997-08

2.  Surgical treatment of the periocular complex and improvement of quality of life in patients with facial paralysis.

Authors:  Douglas K Henstrom; Robin W Lindsay; Mack L Cheney; Tessa A Hadlock
Journal:  Arch Facial Plast Surg       Date:  2011 Mar-Apr

3.  Functional markers of selenium status: UK Food Standards Agency workshop report.

Authors:  Rachel Elsom; Peter Sanderson; John E Hesketh; Malcolm J Jackson; Susan J Fairweather-Tait; Björn Akesson; Jean Handy; John R Arthur
Journal:  Br J Nutr       Date:  2006-11       Impact factor: 3.718

4.  Outcome of orbital decompression for disfiguring proptosis in patients with Graves' orbitopathy using various surgical procedures.

Authors:  M P Mourits; H Bijl; M A Altea; L Baldeschi; K Boboridis; N Currò; A J Dickinson; A Eckstein; M Freidel; C Guastella; G J Kahaly; R Kalmann; G E Krassas; C M Lane; J Lareida; C Marcocci; M Marino; M Nardi; Ch Mohr; C Neoh; A Pinchera; J Orgiazzi; S Pitz; P Saeed; M Salvi; S Sellari-Franceschini; M Stahl; G von Arx; W M Wiersinga
Journal:  Br J Ophthalmol       Date:  2008-11-21       Impact factor: 4.638

Review 5.  Graves' ophthalmopathy.

Authors:  Rebecca S Bahn
Journal:  N Engl J Med       Date:  2010-02-25       Impact factor: 91.245

6.  Dietary selenium and vitamin E intakes alter beta-adrenergic response of L-type Ca-current and beta-adrenoceptor-adenylate cyclase coupling in rat heart.

Authors:  K Sayar; M Ugur; H Gürdal; O Onaran; O Hotomaroglu; B Turan
Journal:  J Nutr       Date:  2000-04       Impact factor: 4.798

7.  Selenium controls the sex-specific immune response and selenoprotein expression during the acute-phase response in mice.

Authors:  Mette Stoedter; Kostja Renko; Antonia Hög; Lutz Schomburg
Journal:  Biochem J       Date:  2010-07-01       Impact factor: 3.857

Review 8.  Dietary antioxidants: immunity and host defense.

Authors:  María A Puertollano; Elena Puertollano; Gerardo Álvarez de Cienfuegos; Manuel A de Pablo
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

9.  Selenium and the course of mild Graves' orbitopathy.

Authors:  Claudio Marcocci; George J Kahaly; Gerasimos E Krassas; Luigi Bartalena; Mark Prummel; Matthias Stahl; Maria Antonietta Altea; Marco Nardi; Susanne Pitz; Kostas Boboridis; Paolo Sivelli; George von Arx; Maarten P Mourits; Lelio Baldeschi; Walter Bencivelli; Wilmar Wiersinga
Journal:  N Engl J Med       Date:  2011-05-19       Impact factor: 91.245

10.  Characterization of mammalian selenoproteomes.

Authors:  Gregory V Kryukov; Sergi Castellano; Sergey V Novoselov; Alexey V Lobanov; Omid Zehtab; Roderic Guigó; Vadim N Gladyshev
Journal:  Science       Date:  2003-05-30       Impact factor: 47.728
  10 in total
  3 in total

1.  The role of IL-15 and selenium in Graves ophthalmopathy.

Authors:  Se Jin Park; Jae Il Shin
Journal:  Nat Rev Endocrinol       Date:  2011-11-23       Impact factor: 43.330

Review 2.  Thyroid eye disease: towards an evidence base for treatment in the 21st century.

Authors:  Erin F Gillespie; Terry J Smith; Raymond S Douglas
Journal:  Curr Neurol Neurosci Rep       Date:  2012-06       Impact factor: 5.081

3.  Serum Selenium Levels in Patients with Graves Disease: Associations with Clinical Activity and Severity in a Retrospective Case-control Study.

Authors:  Tae Hwan Kim; JaeSang Ko; Bo Ram Kim; Dong Yeob Shin; Eun Jig Lee; Jin Sook Yoon
Journal:  Korean J Ophthalmol       Date:  2021-11-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.